The effects of taxol in triple negative breast cancer cells /

The effects of taxol in triple negative breast cancer cells /

Show other versions (1)

Project Paper (Sarjana Muda Sains (Biologi - Industri)) - Universiti Teknologi Malaysia, 2016

Bibliographic Details
Main Authors:	Amirah 'Aqilah Mat Zaid 1993-, author 637479, Praseetha Prabhakaran 270598, Fakulti Biosains dan Kejuruteraan Perubatan 538915
Format:
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2016
Subjects:	Paclitaxel Cancer

Similar Items

The effects of taxol in triple negative breast cancer cells /
by: Amirah 'Aqilah Mat Zaid 1993-, author 637479
Published: (2016)

The effects of taxol in cervical cancer cells hela /
by: Anis Atiqah Sakmani, 1993-, author 609188, et al.
Published: (2016)

The effects of taxol in cervical cancer cells hela /
by: Anis Atiqah Sakmani, 1993-, author 609188
Published: (2016)

The effects of cisplatin in triple negative breast cancer cells /
by: Farah Sahira Mohd Khalil, 1993- , author 609191, et al.
Published: (2016)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422, et al.
Published: (2017)

The anticancer effects of curcumin on triple-negative breast cancer cells /
by: Nur Arifah Husin Basri, 1994-, author 620226, et al.
Published: (2017)

Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
by: Jia-xin Qiao, et al.
Published: (2024-12-01)

The anticancer effects of retinoic acid on triple negative breast cancer cells /
by: Emirul Iskandar Roslee, 1994- , author 612607, et al.
Published: (2017)

Effects of combined cisplatin and clinacanthus nutans on gene expression of MDA-MB-231 breast cancer cells /
by: Yeo, Zhin Leng, 1994-, author 614715, et al.
Published: (2018)

RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer
by: Shumei Huang, et al.
Published: (2025-02-01)

Advancing triple-negative breast cancer treatment through peptide decorated solid lipid nanoparticles for paclitaxel delivery
by: Tahereh Rahdari, et al.
Published: (2025-02-01)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
by: Tatiane da Silva Fernandes, et al.
Published: (2025-01-01)

Anticancer effects of retinoic acid in cervical cancer cells /
by: Sugania Malar Chinapayan, 1994- , 612588, et al.
Published: (2017)

The anticancer effects of Curcumin on cervical cancer cells /
by: Shafiqah Hanim Muhammad Shakib, 1994- , author 611594, et al.
Published: (2017)

Magnetic precision: Unleashing the therapeutic potential of paclitaxel-loaded nanoparticles in breast cancer treatment
by: N. Shobhana, et al.
Published: (2024-06-01)

Computational development of mushroom-6-glucan/paclitaxel as a synergistic complementary medicine for breast cancer therapy
by: Nehal M. EL-Deeb, et al.
Published: (2025-02-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Facile fabrication of TPGS-PCL polymeric nanoparticles for paclitaxel delivery to breast cancer: investigation of antiproliferation and apoptosis induction
by: Tong Chen, et al.
Published: (2024-12-01)

The first experience with intraabdominal chemotherapy in patients with disseminated ovarian cancer
by: A. S. Tyulyandina, et al.
Published: (2014-08-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Effects of cisplatin in cervical cancer cells /
by: Siti Khairunnisa Ishak, 1993-, author 609192, et al.
Published: (2016)

Effect of taxanes on the miR-106 and miR-200c expression in prostate cancer cells in vivo and in vitro
by: D. S. Plevako, et al.
Published: (2023-01-01)

The potential impact of Connexin 43 expression on Bcl-2 protein level and taxane sensitivity in head and neck cancers - in vitro studies
by: Gurbi, Bianka, et al.
Published: (2020)

The combination of Shenhuang plaster and paclitaxel inhibits lung metastasis in breast cancer via modulation of the tumor microenvironment
by: Shiqi Chen, et al.
Published: (2025-02-01)

Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01)

The anticancer effects of retinoic acid on triple negative breast cancer cells /
by: Emirul Iskandar Roslee, 1994- , author 612607
Published: (2017)

High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds
by: Steele, Terry W. J., et al.
Published: (2017)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
by: Yan D, et al.
Published: (2025-02-01)

Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
by: Jana Ismail, et al.
Published: (2025-02-01)

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
by: Yuhan Liu, et al.
Published: (2024-11-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

MicroRNA-dependent mechanisms of taxane resistance in breast cancer
by: V. S. Apollonova, et al.
Published: (2022-12-01)

Effects of combined retinoic acid-clinacanthus nutans treatment in HeLa cancer cells /
by: 614683 Siti Nur Diyana Azmi, 1995- , author, et al.
Published: (2018)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

Combination of paclitaxel with rosiglitazone induces synergistic cytotoxic effects in ovarian cancer cells
by: Binita Patel, et al.
Published: (2024-12-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)